Showing results (201-210 of 239) with videos related to
Sort By:
Pageof 24
Academic Radiology|August 13, 2013
Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphomaFernando Arias-Mendoza, Geoffrey S Payne, Kristen Zakian, et al.Critical Care (London, England)|June 26, 2023
Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1Mihir R Atreya, Natalie Z Cvijanovich, Julie C Fitzgerald, et al.Research Square|February 13, 2023
Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1Mihir R Atreya, Natalie Z Cvijanovich, Julie C Fitzgerald, et al.Neuron|December 8, 2020
Regional, Layer, and Cell-Type-Specific Connectivity of the Mouse Default Mode NetworkJennifer D Whitesell, Adam Liska, Ludovico Coletta, et al.Imaging Neuroscience (Cambridge, Mass.)|August 13, 2025
Charting the path in rodent functional neuroimagingAlessandro Gozzi, Alexia Stuefer, Filomena Grazia Alvino, et al.Annals of Clinical and Translational Neurology|May 17, 2024
Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter MicrostructureMario Tranfa, Luigi Lorenzini, Lyduine E Collij, et al.Elife|April 17, 2023
Biological brain age prediction using machine learning on structural neuroimaging data: Multi-cohort validation against biomarkers of Alzheimer's disease and neurodegeneration stratified by sexIrene Cumplido-Mayoral, Marina García-Prat, Grégory Operto, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2014
Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's diseaseDerek L G Hill, Adam J Schwarz, Maria Isaac, et al.Journal of Medicinal Chemistry|September 18, 2007
1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonistsFabrizio Micheli, Giorgio Bonanomi, Frank E Blaney, et al.The Journal of Clinical Investigation|March 12, 2014
Dominant β-catenin mutations cause intellectual disability with recognizable syndromic featuresValter Tucci, Tjitske Kleefstra, Andrea Hardy, et al.Pageof 24